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Ovarian masses present a special diagnostic challenge when imaging ﬁndings cannot be categorized into benign or malignant
pathology. Ultrasonography (US), Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) are currently used
to evaluate ovarian tumors. US is the ﬁrst-line imaging investigation for suspected adnexal masses. Color Doppler US helps
the diagnosis identifying vascularized components within the mass. CT is commonly performed in preoperative evaluation of
a suspected ovarian malignancy, but it exposes patients to radiation. When US ﬁndings are nondiagnostic or equivocal, MRI can
be a valuable problem solving tool, useful to give also surgical planning information. MRI is well known to provide accurate
information about hemorrhage, fat, and collagen. It is able to identify diﬀerent types of tissue contained in pelvic masses,
distinguishing benign from malignant ovarian tumors. The knowledge of clinical syndromes and MRI features of these conditions
is crucial in establishing an accurate diagnosis and determining appropriate treatment. The purpose of this paper is to illustrate
MRIﬁndingsinneoplasticandnon-neoplasticovarianmasses,whichwereassessedintothreegroups:cystic,solid,andsolid/cystic
lesions. MRI criteria for the correct diagnosis and characteristics for diﬀerentiating benign from malignant conditions are shown
in this paper.
1.Introduction
Ovarian masses present a special diagnostic challenge when
imaging ﬁndings cannot be categorized into benign or
malignant pathology. Ultrasonography (US), Computed
Tomography (CT), and Magnetic Resonance Imaging (MRI)
are currently used to evaluate ovarian tumors. US is the
ﬁrst-line imaging investigation for suspected adnexal masses
helping in detection and characterization of ovarian tumors
[1]. US morphological analysis of adnexal masses is usually
accurate for identifying low risk or high risk lesions [2].
The most important morphological features for high risk
ovarian masses include (a) solid/cystic or solid lesions with
a maximum diameter greater than 4cm; (b) the presence
of irregular, nonfatty, solid vascularized areas greater than
28mm in diameter [3]; (c) the presence of papillary projec-
tion (vegetation) and thick wall and septa greater than 3mm
in a cystic lesion [4]. Color Doppler US helps the diagnosis
identifying vascularized components within the mass [5].
Though US can be inconclusive. An adnexal mass is deﬁned
as indeterminate on US when it cannot be conﬁdently
placed into either the benign or malignant category, even
after thorough interrogation including Doppler assessment,
or for which the site of origin, from the ovary, uterus
or another pelvic structure, remains to be established [6].
CT is commonly performed in preoperative evaluation of
a suspected ovarian malignancy, but it exposes patients to
radiation. When US ﬁndings are nondiagnostic or equivocal,
MRI can be a valuable problem solving tool, an adjunctive
modality for evaluating adnexal lesions, useful to give also
surgical planning information without radiation exposure
[7]. MRI is well known to provide accurate information
about hemorrhage, fat, and collagen [6]. It is able to
identify diﬀerent types of tissue contained in pelvic masses,
distinguishing benign from malignant ovarian tumors, with
an overall accuracy of 88% to 93% [8]. Benign ovarian
diseases can simulate malignancies. The knowledge of clin-
ical syndromes and MRI features of these conditions is2 Journal of Oncology
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Figure 1: Endometrioma. Axial T2-weighted image (a) shows an ovarian cystic mass with intermediate signal intensity. Axial T1 fat
suppression weighted image (b) conﬁrms the haemorrhagic nature of the cyst (endometrioma). Note a mural nodule located posterior
on the left side of the wall (b, arrow). 3D fat-saturated T1-weighted Spoiled Gradient Echo images before (c) and after intravenous contrast
injection with subtraction of precontrast and postcontrast sequences (d) demonstrate the lack of enhancement of the mural nodule due to
blood clot.
crucialinestablishinganaccuratediagnosisanddetermining
appropriate treatment.
The purpose of this paper is to illustrate MRI ﬁndings
in neoplastic and nonneoplastic ovarian masses, separated
into three groups: cystic, solid, and solid/cystic lesions. MRI
criteria for the correct diagnosis and characteristics for
diﬀerentiating benign from suspicious conditions are shown
in this paper.
2.MRI Technical Suggestions
Patients undergoing MRI examination for evaluating an
ovarian mass must fast for 3-4 hours and receive an anti-
spasmodic drug, intramuscularly, 10 minutes before MRI, in
order to reduce bowel peristalsis, also to improve visualiza-
tion of the adnexa and peritoneal surfaces. For an adequate
pelvic MRI evaluation, images must be obtained minimum
in two planes. T1-weighted spin-echo images in the axial
plane and T2-weighted fast spin-echo images obtained in
the axial, sagittal, and coronal planes are usually employed
to evaluate uterus, adjacent organs, pelvic ﬂoor, and broad
ligaments, providing panoramic “morphological” view of
the pelvis. Acquisition of T1- and T2-weighted images is
fundamental for pelvic anatomy and tissue characterization
[9–11].
T1-weighted images with a selective chemical fat-
suppression technique in the axialplane areusefulto identify
blood and fat tissue [11–14]. T2-weighted images with a
selective chemical fat-suppression technique can be usefully
employed to better identify inﬂammation changes or edema.
3Dfat-saturatedT1-weightedSpoiledGradientEcho(SPGR)
images after intravenous contrast material help detection of
solid components into the mass, also improving detection
of peritoneal and omental implants [15, 16]. The use of
small ﬁelds of view (20cm), high-resolution matrixes (256 ×
256), and thin sections (4mm) improves the delineation of
papillary projections into cystic lesions. A body axial T2-
weighted sequence for evaluating retroperitoneal space can
also be used to complete the pelvis evaluation [8].
Severaltypesoftissueandﬂuidcharacterizinganovarian
mass can be distinguished at MRI on the basis of their signal
intensity[17].Cysticlesionsdemonstratelowsignalintensity
on T1-weighted images and very high signal intensity on
T2-weighted images. Solid portions are characterized by
relative high hyperintensity on T2-weighted images. Fat,
hemorrhage, and some high-viscosity, mucin-containing
lesions have high signal intensity on T1-weighted MRI.
Fibrosis or smooth muscle has low or intermediate signal
intensity on T1-weighted MRI and low signal intensity on
T2-weighted images [6].Journal of Oncology 3
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Figure 2: Torsion of right ovary. Coronal T2-weighted image (a) shows an enlarged right ovary with numerous small peripheral cysts
representing displaced follicles (arrow). The right ovary displays a peripheral annular hyperintensity on fat suppressed T1-weighted image
which is indicative of hemorrhagic infarction (b, arrow). 3D fat-saturated T1-weighted Spoiled Gradient Echo image demonstrate the lack
of enhancement of ovarian parenchyma (c, white arrow). Note: normal left ovary with small normal follicle (c, void arrow).
3.Nonneoplastic OvarianConditions
3.1. Cystic Lesions
3.1.1. Polycystic Ovary Syndrome. Polycystic ovary syn-
drome (PCOS) aﬀects approximately 20% of premenopausal
women and is one of the most common endocrinopathies
of women [18]. The follicles in PCOS are typically smaller
in size than those in normal ovaries. US imaging features
include 10 or more follicles with a diameter of 2 to 8mm,
arranged around an echo dense central stroma, with a
threshold stroma/area (S/A) ratio of 0.34 (calculated as
ovarian stromal area to the total area of the ovary). This S/A
ratiohasbeendescribedashavingsensitivityandaspeciﬁcity
of 100% [19].
Typical MRI features include enlarged ovaries, with a
central stroma and multiple small follicles located periph-
erally [20, 21]. Enlargement of the central ovarian stroma
usually shows low intensity on T2-weighted images. The
role of MRI in this condition is excluding other hormone-
stimulating ovarian disorders (like Granulosa cell tumor,
Sclerosing stromal tumor, and Sertoli-Leydig cell tumor,
Steroid cell tumor) by carefully evaluating the presence of
solid lesions within the mass [7]. These conditions generally
appear as a well-deﬁned, heterogeneous enhancing solid
mass with internal cyst or areas of intracellular lipids;
they can be associated with endometrial abnormalities
[4].
3.1.2. Endometrioma. Endometrioma occur as a result of
extrauterine implantation of endometrial epithelium. The
typical US appearance is a complex cystic ovarian mass
with homogenous low-level internal echoes and thick wall
which is usually hypovascular at color Doppler evaluation.
US sensitivity (90.4%) in diagnosing endometrioma is as
high as MRI sensitivity (90%); however MRI is usually
performed after the US because other foci of endometriosis
located in the pelvis and subpelvic spaces can be associated
and for excluding malignant degeneration [22, 23]. MRI
is able to diﬀerentiate endometrioma from endometrioid
adenocarcinoma and clear-cell adenocarcinoma that can
develop within endometrial cysts, with an incidence of 0.6–
1.0% [24]. In these cases, MRI demonstrates solid compo-
nents in the cystic wall clearly enhancing in postcontrast
images. Subtraction images of precontrast and postcontrast
sequences are useful when the enhancement evaluation is
diﬃcult due to the hyperintensity of endometrial cysts
on T1-weighted images (Figure 1). Endometrioma appears
on MRI images as high intensity on T1-weighted images
and relatively low intensity lesions on T2-weighted images
(“shading” eﬀect) manifesting as gradual loss of signal of
dependent layering contents [13, 25]. MRI has been reported
to have a sensitivity of 68–90% and speciﬁcity of 83–98% for
the diagnosis of endometrial cysts [13, 26]. The presence of
multiple, bilateral lesions add speciﬁcity to the diagnosis of
endometriosis[19].Fatsaturationtechniqueishighlyusedto
diﬀerentiate endometrioma from fatty lesions, also showing4 Journal of Oncology
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Figure 3: Pelvic inﬂammatory disease. Left recurrent tuboovarian abscess. Axial T2-weighted image (a) shows a thick wall, complex,
heterogeneously hyperintense, ﬂuid-containing adnexal mass, with internal debris and gas bubbles, that represents the most speciﬁc sign
of an abscess. On axial T1-weighted with fat suppression image (b) there is no signs of hemorrhagic contents within the mass. The sagittal
T2-weighted image (c) demonstrates the involvement of bowel loop characterized by the thickening of the anterior rectal wall.
Table 1: MRI Criteria for benign and suspicious adnexal lesions.
Benign Malignant
Principal criteria
Size <4cm >4cm
Solid components No Solid part of the mass with heterogeneous enhancement pattern
Cystic mass Simple With vegetation and internal structures
Thickness of wall or septa <3mm >3mm
Lobulated mass No Yes
Calciﬁcations Wall of cyst, dense Tiny amorphic
Necrosis No Yes
Papillary projections No Yes, with heterogeneous enhancement pattern
Tumor vessels No Yes, with heterogeneous enhancement pattern
Additional criteria
Lymph nodes Normal (short axis <1cm) Enlarged (short axis >1cm)
Peritoneal implants No Yes
high intensity on T1-weighted images, but with loss of signal
on saturated T1w images.
3.1.3. Peritoneal Inclusion Cyst. Peritoneal inclusion cyst is
deﬁned as ﬂuid accumulation due to adhesions between
ovaries and peritoneal after a pelvic surgery or an inﬂamma-
tory disease. On MRI, this lesion is typically a unilocular or
multilocular cystic mass ranging in size from few millimeters
to 20cm or more. Characteristic MRI ﬁndings are cystic wall
outlined by the pelvic wall, pelvic organs, and bowel loopsJournal of Oncology 5
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Figure 4: Dermoid cyst with small amount of fat. Axial T1- (a) and T2-weighted images with fat suppression (b) show a complex cystic
round lesion with a hypointense nodule (a, b, white arrow) on the right side arising from the right ovary. Observe ovarian parenchyma with
small follicles (b, void arrows). A linear T1 hyperintense portion is located on the upper part of the cyst (a, void arrow). The corresponding
axial fat suppressed T1 weighted image shows the vanishing of the hyperintense part (c, arrow) conﬁrming the presence of small amount of
fat. 3D fat saturated T1-weighted Spoiled Gradient Echo image (d) demonstrates the poor enhancement of mural protrusion corresponding
to Rokitansky nodule (arrow).
[7]. Presence of normal ovary entrapped centrally within the
lesion creating a “spider in a web” appearance is a suggestive
ﬁnding. No mural nodules or enhancing solid components
are seen [19].
3.2. Solid and Solid/Cystic Lesions
3.2.1. Adnexal Torsion. Ovarian torsion most commonly
occurs in the ﬁrst 3 decades of life and frequently involves
the ovary and corresponding fallopian tube. It is more often
associated with an ovarian cyst or mass (approximately in
50% of cases) [27]. US usually shows an enlarged ovary with
follicles distributed peripherally [28]. Doppler US improves
diagnostic possibilities of US showing the lack of ﬂow in the
twisted ovary. However, torsion may occur with incomplete
vascular obstruction. MRI can achieve a more adequate
diagnosis showing typical ﬁndings as the ovary drawn to the
uterus, deviation of the uterus to the side of torsion, straight
vessels draping around the lesion, absence of enhancement
or massive ovarian edema in the case of intermittent torsion,
which is shown as diﬀuse high signal intensity on T2-
weighted images. When hemorrhagic necrosis occurs, the
lesion may exhibit high intensity on T1-weighted images
[29, 30]( Figure 2).
3.2.2. Pelvic Inﬂammatory Disease (PID). Pelvic Inﬂamma-
tory Disease (PID) is a common condition among women in
reproductive age and sexual activity. PID is usually clinically
and laboratory diagnosed (pain, fever, and leukocytosis), but
imaging studies are performed in patients with uncertain
diagnosis, or whose not responding to therapy.
Hydrosalpinx is most often seen on US images as a
hypoechoicadnexalmass,withathickvascularizedwallring,
associated with free ﬂuid in the “cul-de-sac”. In emergency,
CT is usually requested when US ﬁndings are indeterminate
[31, 32]. However MRI can be used in mediate urgency
showing95%sensitivityand89%speciﬁcityinthetuboovar-
ian abscess diagnosis [33]. On MRI, a tubo-ovarian abscess
is characterized by mild signal intensity on T1-weighted and
high signal intensity on T2-weighted images. An irregular
thick wall, markedly enhancing after contrast medium
administration, and stranding in the surrounding fat planes
arecharacteristiceasytoberecognized.Inpatientswithlong-
termuseofintrauterinedevices,actinomycetesareafrequent
causeofchronicinﬂammation.OnMRI,anill-deﬁnedlesion
border resulting from trans fascial inﬂammatory spread may
simulate a malignancy involving the ovary. Relatively low
intensity on T2-weighted images representative of ﬁbrosis
may be an important tool in the accurate diagnosis of this
condition [33, 34]( Figure 3).6 Journal of Oncology
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Figure 5: Bilateral serous cystoadenoma. Axial T1- (a, white arrows) and T2-weighted images (b, arrows) demonstrate bilateral multicystic
ovarian masses. The cystic loculi are small, multiple, separated by thin septa and characterized by homogeneous low signal intensity on
T1 and high intensity on T2-weighted images. Within the left mass there is a posterior small papillary mural projection (b, white arrow).
After contrast media administration, 3D fat-saturated T1-weighted Spoiled Gradient Echo image (c, arrow) demonstrate enhancement of
the mural projection. This is a highly suspicious sign of malignancy. Histology reports left borderline ovarian serous cystoadenoma and right
ovarian serous cystoadenoma.
4. Neoplastic Benign Conditions
4.1. Cystic Tumors
4.1.1. Mature Cystic Teratoma (Dermoid Cyst). Mature cystic
teratoma is the most common ovarian tumor (26–44% of all
ovarian masses). Incidence picks at 30 years old, generally
is found in asymptomatic patients, 90% unilaterally. This
benign tumor consists of ectodermal tissue predominantly
and is lined with keratinized squamous epithelium and skin
appendages. MRI aﬀords a speciﬁc diagnosis by demonstrat-
ing fat tissue signal which is usually demonstrated as high
intensity, the same as subcutaneous fat, on T1-weighted and
T2-weighted images. A selective T1-weighted fat suppression
technique enables diﬀerentiation of cystic teratoma from
hemorrhagic adnexal processes such as endometrial cyst. In
cases of atypical dermoid cysts with scarce lipid components,
chemical shift sequence has been reported to be useful to
detect intracellular or microscopic lipid. Other MRI ﬁndings
for cystic teratomas includes layering or ﬂoating debris, soft-
tissueprotuberances(Rokitanskynodulesordermoidplugs),
and low-signal-intensity teeth. MRI is also collaborative
in identifying complications associated with dermoid cysts,
such as torsion, rupture, and malignant transformation [35].
Malignant transformation is rare and occurs in approx-
imately 2% of mature cystic teratoma. Invasive squamous
carcinomas are the most common malignancy arising in
cystic teratoma. The age of patients has a wide range;
however, postmenopausal women are most predominantly
aﬀected. The tumor tends to spread by direct invasion.
The use of intravenous contrast material may be helpful in
assessing the malignant solid components (Figure 4).
4.1.2. Cystadenomas. Cystadenomas are true cystic epithelial
ovarian neoplasm. Serous cystadenomas are common and
account for approximately 25% of benign ovarian neoplasm.
Incident picks between 20 and 50 years old, bilaterally in 12–
23% of cases. The lining of the cyst is ﬂat or may have small
papillary projections. The typical MRI appearance of serous
cystadenoma is a unilocular cyst with a thin wall (Figure 5).
The presence of blood can vary to heterogeneous signal
intensity. Mucinous cystadenomas are common and account
for approximately 41% of benign ovarian neoplasms. In
contrast to serous tumors, only 2%–5% of cases are bilateral
[35]. Mucinous cystadenomas are multilocular cysts, larger
than serous, containing gelatinous material or ﬂuid of
various viscosities. Therefore, the loculi of the tumors oftenJournal of Oncology 7
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Figure 6: Brenner tumour with mucinous portion. Collision tumour. Axial T2- (a) and T1-weighted (b) images demonstrate an adnexal
multilocularcysticmasswiththinseptationsandasolidposteriorhypointenseportion(a,arrow).Thecysticportionpresentsmultipleloculi
withdiﬀerent contents characterized by diﬀerent signal intensity. The septations and the solid portion present an homogeneous and delayed
enhancement on 3D fat-saturated T1-weighted Spoiled Gradient Echo images (c, arrow). The interface between the solid and the cystic mass
is regular.
show various signal intensities on both T1- and T2-weighted
images (“stained-glass appearance”) (Figure 6). They rarely
appear as unilocular cysts. Presence of thick wall or septa
may suggest borderline lesions while the presence of solid
components suggests carcinoma (Figure 5(c)).
4.2. Solid and Solid/Cystic Tumors
4.2.1. Fibroma, Thecoma, and Fibrothecoma. They are the
most common solid benign tumors of the ovary. The term
ﬁbrothecoma is sometimes applied to these tumors because
of their histological overlap. Fibrothecomas are categorized
as sex-cord-stromal tumors and are rarely malignant. They
are composed of oval or round cells forming variable
amounts of collagen. Fibrothecomas can show mixed low to
high signal intensity on T2-weighted images. They are more
frequently observed during menopause age and sometimes
estrogenic stimuli may be associated with endometrial
pathology [35]. Because of its histological components,
ﬁbromas show predominantly low signal intensity on T2-
weighted images and intermediate signal intensity on T1-
weighted MRI. On the other hand, edema and cystic
formations are relatively common pathologic ﬁndings in
the tumor because of necrosis. Ovarian ﬁbromas can be
infrequently associated with ascites and pleural eﬀusion
(Meigs Syndrome). Ovarian ﬁbromatosis, which is a rare
benign condition, may cause menstrual abnormalities in
young women. This condition can manifest as bilateral ovar-
ian masses with predominant ﬁbrous components, which
show low intensity on T2-weighted images. The presence
of entrapped follicle between the ﬁbrous tissue may be
an important diﬀerentiating feature of this condition from
ovarian ﬁbromas [7]. Diﬀerential diagnosis includes non-
degenerated subserosal uterine leiomyoma. Splaying of the
uterine myometrium to the mass and vascular signal voids
between the uterus and the mass (ﬂow void sign) indicate
uterine leiomyoma [35].
4.2.2. Sclerosing Stromal Tumors. Sclerosing stromal tumors
are rare, benign, sex-cord stromal tumors that occur pre-
dominantly in young women in their second and third
decade of life. On MRI, these tumors consist of hyperintense
cystic components and heterogeneous solid components
with intermediate to high signal intensity on T2-weighted8 Journal of Oncology
images. Dilated vessels may be observed around the tumor,
suggesting tumor hypervascularity. On dynamic contrast-
enhanced MRI, the solid component shows early enhance-
ment, which can be a diagnostic clue of the tumor [7].
4.2.3. Brenner Tumor. Brenner tumor is an uncommon
surface epithelial tumor that accounts for about 2% of
ovarian neoplasms [19]. This tumor can be associated with
other cystic ovarian neoplasms, such as cystadenomas, in
30% of cases (Figure 6). On MRI Brenner tumor typically
exhibits distinct low intensity on T2-weighted images due
to solid components. It is possible to ﬁnd a characteristic
amorphous calciﬁcation within the solid components. If
present, it is characteristic. However MRI may be limited for
detection of calciﬁcations. In these cases, the combination
of calciﬁcations demonstrated by ultrasonography or com-
puted tomography and low intensity on T2-weighted MRI
strongly suggests the diagnosis of Brenner tumor [35].
4.2.4. Cystadenoﬁbroma. Cystadenoﬁbroma is an uncom-
mon epithelial tumor, which is pathologically characterized
by dense ﬁbrous tissue in association with one or many
locules. On MRI, these tumors typically manifest as a
complex cystic mass associated with solid components of
distinct low intensity on T2-weighted images [5, 7, 19].
4.2.5.StrumaOvarii. Ifthedermoidcystiscomposedonlyof
mature thyroid tissue received the name of “struma ovarii.”
Typicallypresentedasamultilocularcystwithheterogeneous
signal intensity in the locules also known as “stained-glass
appearance” on MRI. Thyroid colloid in the cystic space
exhibits low intensity on both T1- and T2-weighted images.
Most of the cases present fat tissue component being helpful
in the ﬁnal diagnosis [7].
5. Discussion and Conclusion
When an adnexal mass is observed on US examination,
MRI can be usefully employed to conﬁrm or refute the
benign nature of the lesion because the property of tissue
characterization. MRI is an eﬀective second conﬁrmatory
test also helpful for problem solving since MRI criteria
for ovarian malignancy are clearly established. Features
suggestive of malignancy (Table 1) include demonstration of
solid, solid/cystic enhancing masses (greater than 4cm in
maximumdiameter)withpapillaryprojectionsandirregular
thick wall and septa (greater 3mm) into a cystic lesion
(the number of septa and the number and dimension of
the vegetations can be suggestive of malignancy). Secondary
feature includes the presence of necrosis in a solid mass
and intratumoral hemorrhage. Heterogeneous and early
enhancement pattern can be suggestive of malignancy.
Finally, the ancillary criteria of involvement of pelvic organs
or the sidewall, ascites, and lymphadenopathy should be
carefully evaluated to distinguish benign from malignant
disease [5].
US is an operator-dependent technique, less panoramic
thanMRIwhichbetteridentifyfattissueandbloodproducts,
that are the main components of most frequent ovarian
masses. In addition, MRI dynamic imaging with gadolinium
chelatesappearspromisingforproblemsolving[36].Combi-
nation of US and MRI minimizes the risk of misdiagnosing
a malignant mass as benign. Especially in younger women,
in whom exposure to ionizing radiation should be as low
as possible to preserve fertility. US remains the primary
imaging modality in ovarian masses but MRI enables a
speciﬁc diagnosis to be made for certain pathologic types
and has greater speciﬁcity in the diagnosis of malignancy
with 91–95% accuracy from diﬀerentiating benign from
malignant adnexal tumors [2, 35]. MRI should be used
for characterization of ovarian masses when US results are
indeterminate or equivocal, especially when tumor markers
are normal or in young patients when conservative surgery is
suggestive.
References
[1] N. Pierce, P. Narayanan, A. Sahdev, R. Reznek, and A. Rockall,
“Ovarian lesions pose diagnostic dilemmas,” Diagnostic Imag-
ing Europe, vol. 24, no. 3, pp. 14–18, 2008.
[2] J. A. Spencer and S. Ghattamaneni, “MR imaging of the
sonographically indeterminate adnexal mass,” Radiology, vol.
256, no. 3, pp. 677–694, 2010.
[3] E. Bouic-Pag` e s ,H .P e r r o c h i a ,S .M ´ erigeaud, P. Y. Giacalone,
andP.Taourel,“Corr´ elationsanatomopathologiques:IRMdes
tumeurs ovariennes primitives,” Journal de Radiologie, vol. 90,
no. 7-8, pp. 787–802, 2009.
[4] S. A. A. Sohaib and R. H. Reznek, “MR imaging in ovarian
cancer,” Cancer Imaging, vol. 7, pp. S119–S129, 2007.
[ 5 ]Y .Y .J e o n g ,E .K .O u t w a t e r ,a n dH .K .K a n g ,“ F r o mt h eR S N A
refresher courses: imaging evaluation of ovarian masses,”
Radiographics, vol. 20, no. 5, pp. 1445–1470, 2000.
[6] J. A. Spencer, R. Forstner, T. M. Cunha, and K. Kinkel, “ESUR
guidelines for MR imaging of the sonographically indeter-
minate adnexal mass: an algorithmic approach,” European
Radiology, vol. 20, no. 1, pp. 25–35, 2010.
[7] K. Tamai, T. Koyama, T. Saga et al., “MR features of
physiologic and benign conditions of the ovary,” European
Radiology, vol. 16, no. 12, pp. 2700–2711, 2006.
[8] M. Bazot, E. Dara¨ ı, J. Nassar-Slaba, C. Lafont, and I.
Thomassin-Naggara, “Value of magnetic resonance imaging
for the diagnosis of ovarian tumors: a review,” Journal of
Computer Assisted Tomography, vol. 32, no. 5, pp. 712–723,
2008.
[9] R. N. Troiano and S. McCarthy, “Magnetic resonance imaging
evaluation of adnexal masses,” Seminars in Ultrasound CT and
MRI, vol. 15, no. 1, pp. 38–48, 1994.
[10] P. J. Woodward and M. Gilfeather, “Magnetic resonance
imaging of the female pelvis,” Seminars in Ultrasound CT and
MRI, vol. 19, no. 1, pp. 90–103, 1998.
[11] E. K. Outwater and D. G. Mitchell, “Magnetic resonance
imagingtechniquesinthepelvis,”MagneticResonanceImaging
Clinics of North America, vol. 2, no. 2, pp. 161–188, 1994.
[12] S. K. Stevens, H. Hricak, and Z. Campos, “Teratomas ver-
sus cystic hemorrhagic adnexal lesions: diﬀerentiation with
proton-selective fat-saturation MR imaging,” Radiology, vol.
186, no. 2, pp. 481–488, 1993.
[13] K. Togashi, K. Nishimura, I. Kimura et al., “Endometrial cysts:
diagnosis with MR imaging,” Radiology, vol. 180, no. 1, pp.
73–78, 1991.Journal of Oncology 9
[14] E. K. Outwater and C. J. Dunton, “Imaging of the ovary
and adnexa: clinical issues and applications of MR imaging,”
Radiology, vol. 194, no. 1, pp. 1–18, 1995.
[15] R. N. Low and J. S. Sigeti, “MR imaging of peritoneal disease:
comparison of contrast-enhanced fast multiplanar spoiled
gradient-recalled andspin-echoimaging,” AmericanJournalof
Roentgenology, vol. 163, no. 5, pp. 1131–1140, 1994.
[16] S. K. Stevens, H. Hricak, and J. L. Stern, “Ovarian lesions:
detection and characterization with gadolinium-enhanced
MR imaging at 1.5 T,” Radiology, vol. 181, no. 2, pp. 481–488,
1991.
[17] E. S. Siegelman and E. K. Outwater, “Tissue characterization
in the female pelvis by means of MR imaging,” Radiology, vol.
212, no. 1, pp. 5–18, 1999.
[18] A. Balen and K. Michelmore, “What is polycystic ovary syn-
drome? Are national views important?” Human Reproduction,
vol. 17, no. 9, pp. 2219–2227, 2002.
[19] M. E. Heilbrun, J. Olpin, and A. Shaaban, “Imaging of benign
adnexal masses: characteristic presentations on ultrasound,
computed tomography, and magnetic resonance imaging,”
Clinical Obstetrics and Gynecology, vol. 52, no. 1, pp. 21–39,
2009.
[20] I. Kimura, K. Togashi, S. Kawakami et al., “Polycystic ovaries:
implications of diagnosis with MR imaging,” Radiology, vol.
201, no. 2, pp. 549–552, 1996.
[21] Y. O. Tanaka, H. Tsunoda, Y. Kitagawa, T. Ueno, H. Yoshikawa,
andY.Saida,“Functioningovariantumors:directandindirect
ﬁndings at MR imaging,” Radiographics, vol. 24, pp. S147–
S166, 2004.
[22] K. Kinkel, K. A. Frei, C. Balleyguier, and C. Chapron, “Diag-
nosis of endometriosis with imaging: a review,” European
Radiology, vol. 16, no. 2, pp. 285–298, 2006.
[23] M. Bazot, I. Thomassin, R. Hourani, A. Cortez, and E.
Darai, “Diagnostic accuracy of transvaginal sonography for
deep pelvic endometriosis,” Ultrasound in Obstetrics and
Gynecology, vol. 24, no. 2, pp. 180–185, 2004.
[24] Y. O. Tanaka, T. Yoshizako, M. Nishida, M. Yamaguchi, K.
Sugimura, and Y. Itai, “Ovarian carcinoma in patients with
endometriosis: MR imaging ﬁndings,” American Journal of
Roentgenology, vol. 175, no. 5, pp. 1423–1430, 2000.
[25] C. A. Gougoutas, E. S. Siegelman, J. Hunt, and E. K.
Outwater, “Pelvic endometriosis: various manifestations and
MR imaging ﬁndings,” American Journal of Roentgenology, vol.
175, no. 2, pp. 353–358, 2000.
[ 2 6 ]E .O u t w a t e r ,M .L .S c h i e b l e r ,R .S .O w e n ,a n dM .D .S c h n a l l ,
“Characterization of hemorrhagic adnexal lesions with MR
imaging: blinded reader study,” Radiology, vol. 186, no. 2, pp.
489–494, 1993.
[27] G. M. Kalish, M. D. Patel, M. L. D. Gunn, and T. J. Dubinsky,
“Computed tomographic and magnetic resonance features of
gynecologic abnormalities in women presenting with acute or
chronic abdominal pain,” Ultrasound Quarterly,v o l .2 3 ,n o .3 ,
pp. 167–175, 2007.
[28] R. D. Bellah and N. T. Griscom, “Torsion of normal uterine
adnexa before menarche: CT appearance,” American Journal
of Roentgenology, vol. 152, no. 1, pp. 123–124, 1989.
[29] S. E. Rha, J. Y. Byun, S. E. Jung et al., “CT and MR imaging
features of adnexal torsion,” Radiographics,v o l .2 2 ,n o .2 ,p p .
283–294, 2002.
[30] F. Minutoli, A. Blandino, M. Gaeta, M. Lentini, and I.
Pandolfo, “Twisted ovarian ﬁbroma with high signal intensity
on T1-weighted MR image: a new sign of torsion of ovarian
tumors?” European Radiology, vol. 11, no. 7, pp. 1151–1154,
2001.
[31] I. Thomassin-Naggara, G. Dubernard, C. Lafont, J. Chopier,
E. Dara¨ ı, and M. Bazot, “Imaging in pelvic inﬂammatory
disease,” Journal de Radiologie, vol. 89, no. 1, pp. 134–141,
2008.
[32] T. A. Tukeva, H. J. Aronen, P. T. Karjalainen, P. Molander, T.
Paavonen, and J. Paavonen, “MR imaging in pelvic inﬂamma-
torydisease:comparisonwithlaparoscopyandUS,”Radiology,
vol. 210, no. 1, pp. 209–216, 1999.
[33] S. H. Kim, D. M. Yang, and K. A. Kim, “Unusual causes
of tubo-ovarian abscess: CT and MR imaging ﬁndings,”
Radiographics, vol. 24, no. 6, pp. 1575–1793, 2004.
[34] J. M. Hawnaur, K. Reynolds, and C. McGettigan, “Magnetic
resonance imaging of actinomycosis presenting as pelvic
malignancy,” The British Journal of Radiology, vol. 72, pp.
1006–1011, 1999.
[35] I. Imaoka, A. Wada, Y. Kaji et al., “Developing an MR imaging
strategy for diagnosis of ovarian masses,” Radiographics, vol.
26, no. 5, pp. 1431–1448, 2006.
[ 3 6 ]P .B .J .V a nV i e r z e n ,L .F .A .G .M a s s u g e r ,S .H .J .R u y s ,a n dJ .
O. Barentsz, “Borderline ovarian malignancy: ultrasound and
fastdynamic MRﬁndings,” EuropeanJournal ofRadiology, vol.
28, no. 2, pp. 136–142, 1998.